Mark M. Jones, M.D. is the newest member of the board of directors of Austin, Texas-based Hanger, Inc., increasing the size of the board to ten members. Dr. Jones, chief of Orthopedic Surgery at Johnston Willis Hospital (HCA) in Richmond, Virginia, is a practicing orthopedic surgeon at OrthoVirginia.
Mark M. Jones, M.D. Joins Hanger Board of Directors
1 min read Premium comments
#hangerincSecondaryaudio#markjones
“As a respected physician with more than 20 years of experience in a field linked closely to the orthotics and prosthetics (O&P) profession, Dr. Jones brings invaluable expertise and first-hand knowledge of patient care to our Board,” said Hanger President and CEO Vinit Asar. “Dr. Jones will provide a valuable leadership addition to our Board, particularly regarding Hanger’s commitment to clinical research and driving superior patient outcomes. His expertise will also help the Company execute as we continue moving forward into the future of value-based care.”
At OrthoVirginia since 1995, Dr. Jones has worked at Johnston Willis Hospital since 2015. He is a member of Johnston Willis Hospital’s Surgical Advisory Committee and has previously served on the board of directors of OrthoVirginia/West End Orthopedic Clinic (2005–2015), and on the board of directors for Westminster-Canterbury of Richmond (2008-2010).
Dr. Jones completed both his orthopedic and general surgery residencies at Virginia Commonwealth University School of Medicine, and then undertook an orthopedic fellowship in Ankle and Foot Surgery at the University of Virginia School of Medicine in 1998. This was followed by an orthopedic fellowship in Arthritis Surgery at the Johns Hopkins School of Medicine in 1989-1990. Dr. Jones earned his M.D. at the Virginia Commonwealth University School of Medicine, and his B.S. from Duke University.
Dr. Jones commented to OTW, “I am excited about Hanger’s leadership position in the orthotics and prosthetics industry, and the opportunity to participate in expanding its strategic differentiation through its investment and commitment to clinical research and outcomes. My perspective as an orthopedic surgeon aligns well with Hanger’s focus on patient-centered care and dedication to empowering human potential.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.